IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Missouri

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Missouri $ 7,695,336.29
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Antigen Laboratories, Inc Sublingual CAT Hair Allergenic Extract $ 244,479.25  
APT Therapeutics, Inc. Therapeutic Use of Human Apyrase $ 244,479.25  
BioMed Valley Discoveries Inc Combination Bacteriolytic Therapy {COLBALT} Project $ 6,403.00 $ 178,957.50
BioMed Valley Discoveries, Inc Phenix Inflammation Project $ 244,479.25  
BioMed Valley Discoveries, Inc. In Vivo FIAU Project $ 69,601.00 $ 174,878.25
BioMed Valley Discoveries, Inc. Phenix Chagas Project $ 43,688.50 $ 72,998.00
BioMed Valley Discoveries, Inc. Phenix Diabetes Project $ 116,561.50 $ 127,917.75
CardiaLen, Inc. Low-Energy Atrial Cardioverter $ 42,532.00 $ 188,481.00
Daya Drug Discoveries Inc Novel Serotonin Agonists/Antagonists for the Treatment of Neurological Disorders $ 83,759.00 $ 102,600.00
Daya Drug Discoveries Inc Small Molecule Steriod Mimics for Molecular Imaging and Therapy of Breast Cancers   $ 20,000.00
ENDOSTIM INC ENDOSTIM MICROSTIMULATOR $ 152,091.15 $ 92,388.10
Evogen, Inc Fully automated point of care platform for the diagnosis of infectious disease and genotyping $ 244,479.25  
Foundation Care LLC Cystic Fibrosis Health Management Program $ 110,000.00 $ 134,479.24
Galera Therapeutics LLC Development of a Drug to Prevent Oral Mucositis in Cancer Patients   $ 244,479.25
Gerhard W. Cibis, M.D., P.C. Automated Video Vision Development Assessment (AVVDA) $ 46,300.50 $ 44,000.00
Immunophotonics, Inc Laser-Assisted Immunotherapy $ 7,821.54 $ 236,657.71
ISTO Technologies Inc Cell-based technology platform $ 244,479.25  
Kereos, Inc Molecularly Targeted Nanostructures for Anticancer Therapy with Cytologic Peptides $ 88,108.50 $ 66,696.50
Kereos, Inc Development of a F-19 Imaging Agent for Early Diagnosis of Cancer and Cardiovascular Disease $ 162,045.00 $ 82,434.24
LipoSpectrum LLC Multi-Dimensional Mass Spectrometry-based Shotgun Lipidomics (MDMS-SL) $ 90,860.00 $ 95,111.00
Mediomics LLC Molecular PINCER-based biosensors for point of care diagnosis $ 244,479.24  
Mobius Therapeutics, LLC Optomycin $ 230,779.50 $ 13,699.74
Pepex Biomedical Composite Conductive Monofilament (CCM) Biosensor Technology- Therapeutic Applications $ 244,479.25  
Sequoia Sciences, Inc. Novel therapeutic vaccine for urinary tract infections $ 159,106.63 $ 85,372.61
Sequoia Sciences, Inc. Novel Small Molecule Therapeutic for the Treatment of Recalcitrant Bacterial Infections $ 244,479.25  
Shear Kershman Laboratories A Tamper Resistant Delivery System for Opiods $ 16,408.50 $ 95,420.10
Stereotaxis, Inc V-Drive $ 244,479.25  
Stereotaxis, Inc TOTAR $ 40,750.00 $ 74,000.00
Stereotaxis, Inc STOP-VT $ 20,580.00 $ 101,804.00
Stereotaxis, Inc. Navigant 3.2 $ 244,479.25  
Stereotaxis, Inc. Vascular Remote Advancement Systems (VRAS) and Next Gen Radiofrequency Generator $ 209,745.50 $ 34,733.75
Stereotaxis, Inc. Odyssey $ 244,479.25  
Stererotaxis, Inc Next Generation Catheters $ 120,134.00 $ 124,345.25
Traxxsson, LLC Biomarkers for Diagnosis and Prognosis of Cancer $ 21,947.00 $ 41,950.00
Veran Medical Technologies, Inc SPiN Drive $ 244,479.25  
VirRx Inc Cancer Therapy with Oncolytic Adenovirus VRX-007   $ 244,479.25
ZeaVision LLC Macular Pigment Reflectometer (MPR) $ 55,852.50 $ 188,626.74
Page Last Reviewed or Updated: 31-Mar-2014